Download Citation
Article Source:
Spironolactone Lowers Portal Hypertension by Inhibiting Liver Fibrosis, ROCK-2 Activity and Activating NO/PKG Pathway in the Bile-Duct-Ligated Rat
Luo W,
Meng Y,
Ji HL,
Pan CQ,
Huang S,
et al.
(2012)
Spironolactone Lowers Portal Hypertension by Inhibiting Liver Fibrosis, ROCK-2 Activity and Activating NO/PKG Pathway in the Bile-Duct-Ligated Rat.
PLOS ONE 7(3): e34230.
https://doi.org/10.1371/journal.pone.0034230